Veracyte, Inc. (VCYT)
44.50
+0.28
(+0.64%)
USD |
NASDAQ |
May 27, 16:00
44.50
0.00 (0.00%)
After-Hours: 19:41
Veracyte EPS Diluted (Quarterly) : 0.353 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insight Molecular Diagnostics, Inc. | -0.1243 |
| Exagen, Inc. | -0.1663 |
| bioAffinity Technologies, Inc. | -0.8077 |
| GRAIL, Inc. | -2.293 |
| Adaptive Biotechnologies Corp. | -0.1288 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 28.71M |
| Revenue (Quarterly) | 139.07M |
| Total Expenses (Quarterly) | 110.36M |
| Enterprise Value | 3.128B |
| Gross Profit Margin (Quarterly) | 72.32% |
| Profit Margin (Quarterly) | 20.64% |
| Earnings Yield | 2.44% |
| Operating Earnings Yield | 2.44% |
| Normalized Earnings Yield | 2.535 |